Hudson Bay Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-325,000
Closed -$39K 1770
2026
Q1
$39K Hold
325,000
﹤0.01% 1276
2025
Q4
$101K Hold
325,000
﹤0.01% 1023
2025
Q3
$94.3K Hold
325,000
﹤0.01% 1075
2025
Q2
$94.2K Hold
325,000
﹤0.01% 1231
2025
Q1
$65K Buy
+325,000
New +$57.2K ﹤0.01% 1180

Other funds holding TDACW

Hudson Bay Capital Management's TDACW Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026, closing a stake of 325,000 shares — an estimated $39K sold.

Hudson Bay Capital Management first reported a position in TDACW in Q1 2025 and held it in 5 quarters. The position peaked at $101K in Q4 2025. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Translational Development Acquisition Corp Warrants position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 325,000 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $39K.
  • Hudson Bay Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and held it in 5 quarters.
  • Hudson Bay Capital Management's Translational Development Acquisition Corp Warrants position peaked at $101K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.